Molnupiravir anti-Covid pill: The antiviral drug Molnupiravir was originally developed to treat the flu. It's meant for adults at risk for progressing to severe Covid or hospitalisation
World's first oral anti-Covid pill, Molnupiravir, has been approved by the UK and is likely to green light in India soon. It's been hailed as a gamechanger in the fight against Covid-19.
Here's all you need to know about the anti-Covid pill:
- Approved for use in the UK, likely to get nod in India soon
- First oral medicine in the world to be approved for use against Covid
- Developed by the pharmaceutical companies Ridgeback Biotherapeutics and Merck, Sharp and Dohme
- The antiviral drug molnupiravir was originally developed to treat the flu
- Meant for adults at risk for progressing to severe Covid or hospitalisation
- To be given to patients within 5 days of symptoms appearing
- Will be given twice a day to patients recently diagnosed with Covid
- Molnupiravir works by disrupting the virus’s reproduction.
- Reduces the risk of hospitalisation or Covid death by 50%
- Ineffective if it’s taken after the patient is hospitalised
- The treatment can be given to both vaccinated and unvaccinated patients
Also Read/Watch: Britain clears Merck’s pill to treat Covid-19: here’s all you need to know about molnupiravir
Watch More Covid Video News and Latest Covid Updates on editorji.com
